Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick C Walsh

Showing results (291-300 of 361) with videos related to

Pageof 37
Sort By:
The Prostate|September 11, 2013
Pathological and oncologic outcomes for men with positive lymph nodes at radical prostatectomy: The Johns Hopkins Hospital 30-year experiencePhillip M Pierorazio, Michael A Gorin, Ashley E Ross, et al.
The Prostate|January 22, 2026
Treatment Response and Outcomes of Prostate Cancer Patients Carrying the Germline MMS22L F722fs MutationMayuko Kanayama, Violet A Daniels, Marta Gielzak, et al.
The Prostate|October 19, 2002
Sequence variants in the human 25-hydroxyvitamin D3 1-alpha-hydroxylase (CYP27B1) gene are not associated with prostate cancer riskGregory A Hawkins, Scott D Cramer, Siqun L Zheng, et al.
BJU International|June 14, 2013
Trends in immediate perioperative morbidity and delay in discharge after open and minimally invasive radical prostatectomy (RP): a 20-year institutional experiencePhillip M Pierorazio, Jeffrey K Mullins, Ashley E Ross, et al.
Clinical Genitourinary Cancer|September 19, 2019
PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical ProstatectomyMark C Markowski, Yongmei Chen, Zhaoyong Feng, et al.
The Prostate|September 16, 2004
Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarraysDennis A Faith, William B Isaacs, James D Morgan, et al.
European Urology|April 30, 2015
Utility of Risk Models in Decision Making After Radical Prostatectomy: Lessons from a Natural History Cohort of Intermediate- and High-Risk MenAshley E Ross, Kasra Yousefi, Elai Davicioni, et al.
The Prostate|January 24, 2008
Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patientsJielin Sun, Ethan M Lange, Sarah D Isaacs, et al.
International Journal of Cancer|April 12, 2002
Transmission/disequilibrium tests of androgen receptor and glutathione S-transferase pi variants in prostate cancer familiesGloria Y F Ho, Michael Knapp, Diha Freije, et al.
BJU International|October 24, 2013
Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomyJennifer L Beebe-Dimmer, William B Isaacs, Kimberly A Zuhlke, et al.
Pageof 37

Showing results (291-300 of 361) with videos related to

Sort By:
Pageof 37
The Prostate|September 11, 2013
Pathological and oncologic outcomes for men with positive lymph nodes at radical prostatectomy: The Johns Hopkins Hospital 30-year experiencePhillip M Pierorazio, Michael A Gorin, Ashley E Ross, et al.
The Prostate|January 22, 2026
Treatment Response and Outcomes of Prostate Cancer Patients Carrying the Germline MMS22L F722fs MutationMayuko Kanayama, Violet A Daniels, Marta Gielzak, et al.
The Prostate|October 19, 2002
Sequence variants in the human 25-hydroxyvitamin D3 1-alpha-hydroxylase (CYP27B1) gene are not associated with prostate cancer riskGregory A Hawkins, Scott D Cramer, Siqun L Zheng, et al.
BJU International|June 14, 2013
Trends in immediate perioperative morbidity and delay in discharge after open and minimally invasive radical prostatectomy (RP): a 20-year institutional experiencePhillip M Pierorazio, Jeffrey K Mullins, Ashley E Ross, et al.
Clinical Genitourinary Cancer|September 19, 2019
PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical ProstatectomyMark C Markowski, Yongmei Chen, Zhaoyong Feng, et al.
The Prostate|September 16, 2004
Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarraysDennis A Faith, William B Isaacs, James D Morgan, et al.
European Urology|April 30, 2015
Utility of Risk Models in Decision Making After Radical Prostatectomy: Lessons from a Natural History Cohort of Intermediate- and High-Risk MenAshley E Ross, Kasra Yousefi, Elai Davicioni, et al.
The Prostate|January 24, 2008
Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patientsJielin Sun, Ethan M Lange, Sarah D Isaacs, et al.
International Journal of Cancer|April 12, 2002
Transmission/disequilibrium tests of androgen receptor and glutathione S-transferase pi variants in prostate cancer familiesGloria Y F Ho, Michael Knapp, Diha Freije, et al.
BJU International|October 24, 2013
Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomyJennifer L Beebe-Dimmer, William B Isaacs, Kimberly A Zuhlke, et al.
Pageof 37